Track topics on Twitter Track topics that are important to you
IsoRay's device for treating recurrent brain tumors, GammaTile therapy, has been granted 510(k) clearance by the FDA. -More-
Fear of share dilution follows FDA approval of the company's GammaTile therapy for recurrent brain tumors
Today's Daily Dose brings you news about promising trial results of Acceleron Pharma's investigational drug Luspatercept in beta-thalassemia; FDA granting Orphan Drug Designation to Cellectar Bioscien...
IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of the Cesium-131 brachytherapy seed, used to treat prostate and other cancers. The Cesium-131 see...
IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. ...
Our mission is to provide innovative solutions for the treatment and diagnosis of disease using medical isotopes that represent significant advancements over existing technology. Through operational e...
We have published hundreds of IsoRay Inc. news stories on BioPortfolio along with dozens of IsoRay Inc. Clinical Trials and PubMed Articles about IsoRay Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IsoRay Inc. Companies in our database. You can also find out about relevant IsoRay Inc. Drugs and Medications on this site too.
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...